BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21966945)

  • 1. Increased inflammatory markers are associated with obesity and not with target organ damage in newly diagnosed untreated essential hypertensive patients.
    Torun D; Ozelsancak R; Yiğit F; Micozkadıoğlu H
    Clin Exp Hypertens; 2012; 34(3):171-5. PubMed ID: 21966945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
    Kartal O; Inal V; Baysan O; Sağlam K
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between inflammation and arterial stiffness in patients with essential hypertension.
    Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M
    Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C; Dimitriadis K; Taxiarchou E; Vasiliadou C; Chartzoulakis G; Tousoulis D; Manolis A; Stefanadis C; Kallikazaros I
    Am J Hypertens; 2006 May; 19(5):462-6. PubMed ID: 16647614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma fibrinogen levels in patients with essential hypertension are related to vascular complications.
    Lechi C; Gaino S; Zuliani V; Tommasoli RM; Faccini G; Fasson R; Arcaro G; Lechi A; Minuz P
    Int Angiol; 2003 Mar; 22(1):72-8. PubMed ID: 12771860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory markers in hypertensive patients and influence of some associated metabolic risk factor.
    Mitu F; Rezuş E; Banu C; Jufă C; Mitu O; Dima-Cozma C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):631-6. PubMed ID: 25341276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
    Sciarretta S; Ferrucci A; Ciavarella GM; De Paolis P; Venturelli V; Tocci G; De Biase L; Rubattu S; Volpe M
    Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating ghrelin levels in obese women: a possible association with hypertension.
    Oner-Iyidoğan Y; Koçak H; Gürdöl F; Oner P; Issever H; Esin D
    Scand J Clin Lab Invest; 2007; 67(5):568-76. PubMed ID: 17763194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1 microglobulin as a new inflammatory marker in newly diagnosed hypertensive patients.
    Vyssoulis GP; Tousoulis D; Antoniades C; Dimitrakopoulos S; Zervoudaki A; Stefanadis C
    Am J Hypertens; 2007 Sep; 20(9):1016-21. PubMed ID: 17765145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension.
    Roselló-Lletí E; de Burgos FG; Morillas P; Cortés R; Martínez-Dolz L; Almenar L; Grigorian L; Orosa P; Portolés M; Bertomeu V; Rivera M
    Am J Hypertens; 2012 Feb; 25(2):236-42. PubMed ID: 22052073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of obesity in Greek hypertensives.
    Efstratopoulos AD; Voyaki SM; Lydakis H; Meikopoulos M; Hini S; Tsikinis Y
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S65-70. PubMed ID: 8872830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total tooth loss and systemic correlates of inflammation: role of obesity.
    Meisel P; Wilke P; Biffar R; Holtfreter B; Wallaschofski H; Kocher T
    Obesity (Silver Spring); 2012 Mar; 20(3):644-50. PubMed ID: 21760638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of inflammatory markers in hypertensives with target organ damage.
    Jastrzebski M; Czarnecka D; Rajzer M; Kawecka-Jaszcz K
    Kardiol Pol; 2006 Aug; 64(8):802-9; discussion 810-1. PubMed ID: 16981055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.
    Akbartabartoori M; Lean ME; Hankey CR
    Eur J Clin Nutr; 2008 Jan; 62(1):1-9. PubMed ID: 17342166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of obesity with inflammation in chronic kidney disease: a cross-sectional study.
    Ramkumar N; Cheung AK; Pappas LM; Roberts WL; Beddhu S
    J Ren Nutr; 2004 Oct; 14(4):201-7. PubMed ID: 15483779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men.
    Galletti F; D'Elia L; De Palma D; Russo O; Barba G; Siani A; Miller MA; Cappuccio FP; Rossi G; Zampa G; Strazzullo P
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):300-6. PubMed ID: 21920718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of orthostatic hypertension and hypotension with target organ damage in middle and old-aged hypertensive patients].
    Fan XH; Sun K; Zhou XL; Zhang HM; Wu HY; Hui RT
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):220-4. PubMed ID: 21418863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.